BEMA Buprenorphine Phase 2 Study Results Selected for Presentation at Pain Week 2010
(Raleigh, N.C.) BioDelivery Sciences International, Inc. (Nasdaq:BDSI) announced today that its abstract showing the results of a Phase 2 clinical study of BEMA Buprenorphine in the treatment of pain has been selected for oral presentation at Pain Week 2010, a national conference educating frontline clinicians who are faced with treating patients with pain. The presentation will take place on Friday, September 10, as part of the 7:00 - 9:00 AM podium presentation session. (more…)

(Raleigh, N.C.) Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will present at the BMO Capital Markets 10th Annual Focus on Healthcare Conference in New York, NY on Thursday, August 5 at 1:15 p.m. ET.
